Mestag Therapeutics News and Activities

Acquisition, funding and merger involving Mestag Therapeutics.

• Mestag Therapeutics has just announced a $40 Million fundraising (posted on March 19 2026).

View the org chart displaying its 14 main executives

Most searched biographies at Mestag Therapeutics

• Susan Hill, Chief Executive Officer
• Fiona MacLaughlin, Director
• Issi Rozen, Director

Popular executive movements at Mestag Therapeutics

• Lindsey Rolfe has joined the company as Chief Medical Officer  (posted on March 19 2026).
• Pascal Merchiers has joined the company as Chief Development Officer  (posted on March 19 2026).

Create your alert
to follow the executive moves at Mestag Therapeutics.

Mestag Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Mestag Therapeutics

• Press Releases » Mestag Therapeutics
• News & Events » Mestag Therapeutics

Social media about Mestag Therapeutics

• Mestag Therapeutics on Wikipedia, Google News & Yahoo Finance
• Mestag Therapeutics on LinkedIn, X (Twitter) & YouTube